U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

2017
422
Name Type Language
EMICIZUMAB
INN   USAN   WHO-DD  
INN   USAN  
Official Name English
Emicizumab [WHO-DD]
Common Name English
EMICIZUMAB [MI]
Common Name English
emicizumab [INN]
Common Name English
EMICIZUMAB [JAN]
Common Name English
EMICIZUMAB [USAN]
Common Name English
IMMUNOGLOBULIN G4-KAPPA, BISPECIFIC, ANTI-(HOMO SAPIENS F9A (ACTIVATED COAGULATION FACTOR F9, ACTIVATED COAGULATION FACTOR IX) AND ANTI-(HOMO SAPIENS F10 (COAGULATION FACTOR 10, COAGULATION FACTOR X)), HUMANIZED MONOCLONAL ANTIBODY
Common Name English
Classification Tree Code System Code
WHO-ATC B02BX06
Created by admin on Sat Dec 16 11:19:19 UTC 2023 , Edited by admin on Sat Dec 16 11:19:19 UTC 2023
FDA ORPHAN DRUG 416913
Created by admin on Sat Dec 16 11:19:19 UTC 2023 , Edited by admin on Sat Dec 16 11:19:19 UTC 2023
Code System Code Type Description
DRUG CENTRAL
5268
Created by admin on Sat Dec 16 11:19:19 UTC 2023 , Edited by admin on Sat Dec 16 11:19:19 UTC 2023
PRIMARY
CAS
1610943-06-0
Created by admin on Sat Dec 16 11:19:19 UTC 2023 , Edited by admin on Sat Dec 16 11:19:19 UTC 2023
PRIMARY
SMS_ID
100000169091
Created by admin on Sat Dec 16 11:19:19 UTC 2023 , Edited by admin on Sat Dec 16 11:19:19 UTC 2023
PRIMARY
INN
10115
Created by admin on Sat Dec 16 11:19:19 UTC 2023 , Edited by admin on Sat Dec 16 11:19:19 UTC 2023
PRIMARY
DAILYMED
7NL2E3F6K3
Created by admin on Sat Dec 16 11:19:19 UTC 2023 , Edited by admin on Sat Dec 16 11:19:19 UTC 2023
PRIMARY
USAN
EF-03
Created by admin on Sat Dec 16 11:19:19 UTC 2023 , Edited by admin on Sat Dec 16 11:19:19 UTC 2023
PRIMARY
WIKIPEDIA
Emicizumab
Created by admin on Sat Dec 16 11:19:19 UTC 2023 , Edited by admin on Sat Dec 16 11:19:19 UTC 2023
PRIMARY
LACTMED
Emicizumab
Created by admin on Sat Dec 16 11:19:19 UTC 2023 , Edited by admin on Sat Dec 16 11:19:19 UTC 2023
PRIMARY
MERCK INDEX
m12056
Created by admin on Sat Dec 16 11:19:19 UTC 2023 , Edited by admin on Sat Dec 16 11:19:19 UTC 2023
PRIMARY
DRUG BANK
DB13923
Created by admin on Sat Dec 16 11:19:19 UTC 2023 , Edited by admin on Sat Dec 16 11:19:19 UTC 2023
PRIMARY
EVMPD
SUB182706
Created by admin on Sat Dec 16 11:19:19 UTC 2023 , Edited by admin on Sat Dec 16 11:19:19 UTC 2023
PRIMARY
FDA UNII
7NL2E3F6K3
Created by admin on Sat Dec 16 11:19:19 UTC 2023 , Edited by admin on Sat Dec 16 11:19:19 UTC 2023
PRIMARY
RXCUI
1989795
Created by admin on Sat Dec 16 11:19:19 UTC 2023 , Edited by admin on Sat Dec 16 11:19:19 UTC 2023
ALTERNATIVE
RXCUI
1989794
Created by admin on Sat Dec 16 11:19:19 UTC 2023 , Edited by admin on Sat Dec 16 11:19:19 UTC 2023
PRIMARY
NCI_THESAURUS
C159541
Created by admin on Sat Dec 16 11:19:19 UTC 2023 , Edited by admin on Sat Dec 16 11:19:19 UTC 2023
PRIMARY
ACTIVE MOIETY
EMICIZUMAB
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966